GeneDx Holdings (WGS) Change in Acquisitions & Divestments (2023 - 2026)

GeneDx Holdings (WGS) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $8.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $8.5 million; the TTM figure through Mar 2026 stood at $52.5 million (up 49.04% YoY), while the FY2025 annual figure was $44.0 million, up 7.09% from the prior year.
• Change in Acquisitions & Divestments retreated to $8.5 million in Q1 2026 per WGS's latest filing, from $44.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $44.0 million in Q4 2025 and bottomed at -$5.3 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $13.9 million across 4 years, with a median of $12.3 million in 2024.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 1364.09% in 2024 and fell as far as 46.16% in 2024.
• GeneDx Holdings' Change in Acquisitions & Divestments stood at $1.1 million in 2023, then jumped by 1364.09% to $16.1 million in 2024, then jumped by 173.02% to $44.0 million in 2025, then slumped by 80.67% to $8.5 million in 2026.
• Business Quant data shows WGS's Change in Acquisitions & Divestments at $8.5 million in Q1 2026, $44.0 million in Q4 2025, and $16.1 million in Q4 2024.